Baricitinib as Treatment for Coronavirus Disease 2019 (COVID-19): Friend or Foe of the Pancreas?
Clin Infect Dis
.
2021 Dec 6;73(11):e3977-e3978.
doi: 10.1093/cid/ciaa1209.
Authors
Christopher Cerda-Contreras
1
,
Laura Nuzzolo-Shihadeh
2
,
Adrián Camacho-Ortiz
2
,
Eduardo Perez-Alba
2
Affiliations
1
Servicio de Medicina Interna, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey Mexico.
2
Servicio de Infectología, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey Mexico.
PMID:
32797239
PMCID:
PMC7454364
DOI:
10.1093/cid/ciaa1209
No abstract available
Publication types
Letter
Comment
MeSH terms
Azetidines
COVID-19 Drug Treatment*
Humans
Pancreas
Purines
Pyrazoles
SARS-CoV-2
Sulfonamides
Substances
Azetidines
Purines
Pyrazoles
Sulfonamides
baricitinib